Latest Vancomycin Stories
EXTON, Pa., July 21 /PRNewswire-FirstCall/ -- ViroPharma Incorporated's (Nasdaq: VPHM) second quarter financial results for 2010 are expected to be released on Wednesday, July 28, 2010 before the open of the U.S.
SAN DIEGO, July 8 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced it has received a $500,000 milestone payment from Cempra Pharmaceuticals, Inc. pursuant to the terms of a licensing agreement between the companies.
Bees could have a key role to play in urgently-needed new treatments to fight the virulent MRSA bug.
MALVERN, Pa., June 22 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that surveyed infectious disease specialists anticipate changes in their future prescribing patterns for treating hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections.
EXTON, Pa., June 21 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today provided an update on recent progress in Cinryze(TM) (C1 Esterase Inhibitor [Human]) manufacturing expansion activities.
CHICAGO, June 14 /PRNewswire-USNewswire/ -- MRSA Survivors Network with MRSA survivors, family members and other victims of healthcare-acquired infections unite across the globe and on World MRSA Day, October 2, 2010 in a grassroots movement to raise awareness and push for more mandated reporting of infections, MRSA screening laws, funds to raise awareness and educate the public on prevention, which will save lives. (Logo: http://photos.prnewswire.com/prnh/20090825/DC65136LOGO ) Jeanine...
EXTON, Pa., June 3 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that William Roberts, vice president, corporate communications of ViroPharma, will present at the Jefferies 2010 Global Life Sciences Conference at 4:00 P.M. ET on Wednesday, June 9, 2010.
Researchers shed light on the mode of action; promising approach for new antibiotics.
WOBURN, Mass., May 24 /PRNewswire/ -- AdvanDx today announced that it will offer the BinaxNOWÂ® PBP2a test from Inverness Medical Innovations, Inc. (Waltham, MA) to customers in the United States.
A study recently published has found that the number of children hospitalized with dangerous drug-resistant staph infections surged 10-fold in recent years.
Enterococcus is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is a main constituent of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans, especially in the nosocomial environment, where the naturally high levels of antibiotic resistance found in E. faecalis contribute to its pathogenicity. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of...
Enterococcus faecalis "“ formerly classified as part of the Group D Streptococcus system "“ is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is one of the main constituents of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of the cases. It is a non-motile, facultatively anaerobic...
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.